【摘 要】
:
Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate and is notoriously refractory to multiple cancer treatments. In recent years, cancer therapy h
【机 构】
:
Department of Medicine, Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY, US